Cutone, A.; Rosa, L.; Bonaccorsi di Patti, M.C.; Iacovelli, F.; Conte, M.P.; Ianiro, G.; Romeo, A.; Campione, E.; Bianchi, L.; Valenti, P.;
et al. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics 2022, 14, 2111.
https://doi.org/10.3390/pharmaceutics14102111
AMA Style
Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P,
et al. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics. 2022; 14(10):2111.
https://doi.org/10.3390/pharmaceutics14102111
Chicago/Turabian Style
Cutone, Antimo, Luigi Rosa, Maria Carmela Bonaccorsi di Patti, Federico Iacovelli, Maria Pia Conte, Giusi Ianiro, Alice Romeo, Elena Campione, Luca Bianchi, Piera Valenti,
and et al. 2022. "Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models" Pharmaceutics 14, no. 10: 2111.
https://doi.org/10.3390/pharmaceutics14102111
APA Style
Cutone, A., Rosa, L., Bonaccorsi di Patti, M. C., Iacovelli, F., Conte, M. P., Ianiro, G., Romeo, A., Campione, E., Bianchi, L., Valenti, P., Falconi, M., & Musci, G.
(2022). Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics, 14(10), 2111.
https://doi.org/10.3390/pharmaceutics14102111
